SCHEMBL241029

SCHEMBL241029

CC(C)c1ncccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL28070874 0.97 HDAC8 (0.33)
Phosphine SCHEMBL29001674 0.97 HDAC8 (0.33)
SCHEMBL18762857 0.78
SCHEMBL11994398 0.77 CYP2A6 (0.40)
SCHEMBL24724749 0.75
SCHEMBL21031336 0.75
SCHEMBL21191727 0.75 HDAC8 (0.32)
SCHEMBL20567997 0.75
SCHEMBL22423794 0.75 HDAC8 (0.32)
SCHEMBL310530 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2461 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3998261-B1 PYRIMIDIN-2-YLAMINO-1H-PYRAZOLS AS LRRK2 INHIBITORS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS DENALI THERAPEUTICS INC (US) 2025-05-07 EP claimed
CN-104744376-A Preparation method of 2-isopropyl pyrimidine derivative CHANGSHA SHENCHENG BIOLOG TECHNOLOGY CO LTD 2015-07-01 CN claimed
CN-103022556-A Lithium-ion battery and electrolyte thereof NINGDE AMPEREX TECHNOLOGY LTD 2013-04-03 CN claimed
US-6147098-A USEFUL IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM, PULMONARY SYSTEM, GASTROINTESTINAL SYSTEM AND ENDOCRINOLOGIC SYSTEM NOVO NORDISK A/S (DK) 2000-11-14 US claimed
US-20250129044-A1 PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS XENON PHARMACEUTICALS INC. (CA) 2025-04-24 US disclosed
WO-2025027567-A1 PROCESS FOR PREPARING MAVACAMTEN AND PROCESS INTERMEDIATE OLON S.P.A. (IT) 2025-02-06 WO disclosed
US-12202826-B2 N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway REDX PHARMA PLC (GB) 2025-01-21 US disclosed
CN-119095609-A Agent for eliminating obesity and composition for eliminating obesity 丸善制药株式会社 2024-12-06 CN disclosed
US-12043607-B2 HDAC inhibitors and therapeutic use thereof TANGO THERAPEUTICS, INC. (US) 2024-07-23 US disclosed
US-12043607-B2 HDAC inhibitors and therapeutic use thereof TANGO THERAPEUTICS, INC. (US) 2024-07-23 US disclosed
CN-118359609-A Heterocyclic compounds, their preparation and use 益方生物科技(上海)股份有限公司 2024-07-19 CN disclosed
US-20240239777-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2024-07-18 US disclosed
EP-0193973-A1 Method of preparation of 2-alkylpyrimidine by dehydrogenation of 2-alkyltetrahydropyrimidine THE DOW CHEMICAL COMPANY (US) 1986-09-10 EP disclosed
EP-0192297-A1 Process for the preparation of A 2-alkylpyrimidine STAMICARBON B.V. (NL) 1986-08-27 EP disclosed
US-4493929-A Preparation of 2-alkylpyrimidines THE DOW CHEMICAL COMPANY (US) 1985-01-15 US disclosed
US-4474599-A 1-(Pyridyl)-1H-1,2,3-triazole derivatives, and use as herbicidal agents THE DOW CHEMICAL COMPANY (US) 1984-10-02 US disclosed
EP-0117882-A1 Novel aminopropylpivalamides and a method of preparation THE DOW CHEMICAL COMPANY (US) 1984-09-12 EP disclosed
US-4433037-A WITH COBALT AMINE OXIDIZING AGENT AND COMPLEXING AGENT EASTMAN KODAK COMPANY (US) 1984-02-21 US disclosed
US-4055411-A 5-NITRO-PYRIMIDINES CIBA-GEIGY CORPORATION (US) 1977-10-25 US disclosed
US-3948914-A PLANT GROWTH REGULATORS CIBA-GEIGY CORPORATION (US) 1976-04-06 US disclosed